Published : May-2018
No. of Pages : 228
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Male Hypogonadism to Male Health Clinical Trials 16
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Male Hypogonadism to Male Health Clinical Trials 21
Clinical Trials by Phase in E7 Countries 23
Clinical Trials in E7 Countries by Trial Status 24
Clinical Trials by Phase 25
In Progress Trials by Phase 26
Clinical Trials by Trial Status 27
Clinical Trials by End Point Status 29
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in Male Hypogonadism Therapeutics Clinical Trials 34
Prominent Drugs 36
Latest Clinical Trials News on Male Hypogonadism 37
Mar 19, 2018: Mereo BioPharma Announces Positive Top-Line Results from Phase 2b Study of BGS-649 for the Treatment of Hypogonadotropic Hypogonadism in Obese Men 37
Clinical Trial Profile Snapshots 38
Appendix 226
Abbreviations 226
Definitions 226
Research Methodology 227
Secondary Research 227
About GlobalData 228
Contact Us 228
Source 228
List of Tables
Male Hypogonadism Therapeutics, Global, Clinical Trials by Region, 2018* 7
Male Hypogonadism Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Male Hypogonadism Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Male Hypogonadism Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
Male Hypogonadism Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Male Hypogonadism Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Male Hypogonadism Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018* 14
Male Hypogonadism Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 15
Proportion of Male Hypogonadism to Male Health Clinical Trials, G7 Countries (%), 2018* 17
Male Hypogonadism Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Male Hypogonadism Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 20
Proportion of Male Hypogonadism to Male Health Clinical Trials, E7 Countries (%), 2018* 22
Male Hypogonadism Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23
Male Hypogonadism Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 24
Male Hypogonadism Therapeutics, Global, Clinical Trials by Phase, 2018* 25
Male Hypogonadism Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 26
Male Hypogonadism Therapeutics, Global, Clinical Trials by Trial Status, 2018* 28
Male Hypogonadism Therapeutics Clinical Trials, Global, by End Point Status, 2018* 29
Male Hypogonadism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 30
Male Hypogonadism Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 31
Male Hypogonadism Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 33
Male Hypogonadism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 35
Male Hypogonadism Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 36
List of Figures
Male Hypogonadism Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Male Hypogonadism Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Male Hypogonadism Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Male Hypogonadism Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
Male Hypogonadism Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Male Hypogonadism Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Male Hypogonadism Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018* 14
Male Hypogonadism Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2018* 15
Proportion of Male Hypogonadism to Male Health Clinical Trials, G7 Countries (%), 2018* 16
Male Hypogonadism Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Male Hypogonadism Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
Proportion of Male Hypogonadism to Male Health Clinical Trials, E7 Countries (%), 2018* 21
Male Hypogonadism Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23
Male Hypogonadism Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 24
Male Hypogonadism Therapeutics, Global, Clinical Trials by Phase (%), 2018* 25
Male Hypogonadism Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 26
Male Hypogonadism Therapeutics, Global, Clinical Trials by Trial Status, 2018* 27
Male Hypogonadism Therapeutics Clinical Trials, Global, by End Point Status, 2018* 29
Male Hypogonadism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 30
Male Hypogonadism Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 31
Male Hypogonadism Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 32
Male Hypogonadism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 34
Male Hypogonadism Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 36
GlobalData Methodology 227
